PALI insider transaction filings
PALISADE BIO, INC. — 33 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen PALI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Finley John David — CEO, CFO, Director | Gift (G): 88,400 @ $0 · Gift (G): 88,400 @ $0 | EDGAR |
| 2026-07-10 | 4 | Baltera Robert Jr. — Director | Purchase (P): 20,000 @ $1.99 · Purchase (P): 25,000 @ $1.96 | EDGAR |
| 2026-07-08 | 4 | Baltera Robert Jr. — Director | Purchase (P): 20,000 @ $2.05 · Purchase (P): 30,000 @ $2.03 | EDGAR |
| 2026-07-08 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Option exercise (M): 131,167 · Sale (S): 51,880 @ $2.05 · Option exercise (M): 131,167 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | Finley John David — CEO, CFO, Director | Option exercise (M): 335,167 · Sale (S): 146,798 @ $2.07 · Option exercise (M): 133 @ $0.70 · Option exercise (M): 335,167 (derivative) @ $0 · Option exercise (M): 133 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Baltera Robert Jr. — Director | Purchase (P): 20,000 @ $1.98 · Purchase (P): 10,000 @ $1.98 | EDGAR |
| 2026-06-18 | 4 | Baltera Robert Jr. — Director | Grant/award (A): 336,904 | EDGAR |
| 2026-06-12 | 4 | Wei Binxian — Director | Grant/award (A): 592,300 · Option exercise (M): 20,200 · Option exercise (M): 20,200 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Williams Donald Allen — Director | Grant/award (A): 1,498,900 · Option exercise (M): 60,666 · Option exercise (M): 60,666 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Chuang Emil — Director | Grant/award (A): 592,300 · Option exercise (M): 20,200 · Option exercise (M): 20,200 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Zwick Jordan Michael — Director | Grant/award (A): 336,904 | EDGAR |
| 2026-02-13 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Option exercise (M): 8,000 · Sale (S): 1,989 @ $1.75 · Option exercise (M): 8,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Finley John David — CEO, CFO, Director | Option exercise (M): 13,333 · Sale (S): 3,896 @ $1.75 · Option exercise (M): 13,333 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Grant/award (A): 787,000 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Finley John David — CEO, CFO, Director | Grant/award (A): 2,011,000 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Williams Donald Allen — Director | Purchase (P): 5,000 @ $1.67 | EDGAR |
| 2026-01-13 | 4 | Williams Donald Allen — Director | Purchase (P): 5,000 @ $1.88 | EDGAR |
| 2025-11-06 | 4/A | Williams Donald Allen — Director | Grant/award (A): 182,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4/A | Wei Binxian — Director | Grant/award (A): 60,600 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4/A | Chuang Emil — Director | Grant/award (A): 60,600 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Williams Donald Allen — Director | Grant/award (A): 1,538,700 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Wei Binxian — Director | Grant/award (A): 510,700 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Grant/award (A): 7,665,800 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Finley John David — CEO, CFO, Director | Grant/award (A): 9,179,400 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Chuang Emil — Director | Grant/award (A): 510,700 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Williams Donald Allen — Director | Grant/award (A): 64,400 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Wei Binxian — Director | Grant/award (A): 18,800 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Grant/award (A): 289,000 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Finley John David — CEO, CFO, Director | Grant/award (A): 323,400 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Chuang Emil — Director | Grant/award (A): 18,800 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | Chuang Emil — Director | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | Jones Mitchell Lawrence — Chief Medical Officer | Grant/award (A): 29,000 (derivative) @ $0 · Grant/award (A): 24,000 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | Finley John David — CEO, CFO, Director | Grant/award (A): 47,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — PALISADE BIO, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-12-04 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-10-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-10-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-10-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-26 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PALI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →